Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
GENERAC POWER SYSTEMS INC	WAUKESHA WI 53187

International Classification(s)

• H02J:CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR D....
• B60W:CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT....

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Dietrich, Alan	Madison, US	1	17
# of filed Patents : 1 Total Citations : 17
Iles, Robert	Delafield, US	10	109
# of filed Patents : 10 Total Citations : 109
Thimmesch, David	Franklin, US	1	17
# of filed Patents : 1 Total Citations : 17
Wilcox, Steven	Delafield, US	9	200
# of filed Patents : 9 Total Citations : 200
Wischstadt, Greg	Wales, US	16	222
# of filed Patents : 16 Total Citations : 222

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Apr 15, 2025

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
October 15, 2013	US,8558512,B2   US8558512B2	GRANTED PATENT AS SECOND PUBLICATION
December 01, 2011	US,20110291621,A1   US20110291621A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 8354396

Drug identification and treatment method

---

Abstract

---

The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17α-ethynylandrost-5-ene-3β,11β,7α,17β-tetrol, 4α-acetoxy-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 17α-ethynylandrost-5-ene-3β,4β,7α,17β-tetrol, 17α-ethynylandrost-5-ene-3α,4β,7α,17β-tetrol and 17α-ethynylandrost-5-ene-3α,4β,17β-triol-7-one.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• AS2024
• MAFP2024
• AS2021
• AS2021
• MAFP2020
• SULP2016
• FPAY2016
• REMI2016
• AS2015
• AS2014
• I2013
• STCF2012
• AS2012
• AS2012
• AS2010
• P2008
• AS2008
• F2007
• PD2006

Date	Code	Event	Description
Dec 05, 2024	AS	ASSIGNMENT	free format text: RELEASE BY SECURED PARTY;ASSIGNOR:AVENUE VENTURE OPPORTUNITIES FUND, L.P.;REEL/FRAME:069510/0814 Owner name: BIOVIE INC., NEVADA Effective Date: Dec 05, 2024
Jul 15, 2024	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 12TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2553); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 12
Nov 30, 2021	AS	ASSIGNMENT	free format text: SECURITY INTEREST;ASSIGNOR:BIOVIE INC.;REEL/FRAME:058329/0389 Owner name: AVENUE VENTURE OPPORTUNITIES FUND, L.P., NEW YORK Effective Date: Nov 30, 2021
Aug 08, 2021	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEURMEDIX, INC.;REEL/FRAME:057116/0336 Owner name: NEURMEDIX, LLC, CALIFORNIA Effective Date: Jan 25, 2020 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEURMEDIX, LLC;REEL/FRAME:057116/0362 Owner name: NEURMEDIX, INC., CALIFORNIA Effective Date: Aug 08, 2021 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEURMEDIX, INC.;REEL/FRAME:057116/0451 Owner name: BIOVIE INC., CALIFORNIA Effective Date: Aug 08, 2021
Apr 21, 2020	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 8
Sep 15, 2016	SULP	SURCHARGE FOR LATE PAYMENT
Sep 15, 2016	FPAY	FEE PAYMENT	year of fee payment: 4
Aug 26, 2016	REMI	MAINTENANCE FEE REMINDER MAILED
Feb 16, 2015	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RESERVA LLC;REEL/FRAME:035026/0292 Owner name: NEURMEDIX INC., CALIFORNIA Effective Date: Feb 16, 2015
Dec 09, 2014	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARBOR THERAPEUTICS, INC.;REEL/FRAME:046828/0014 Owner name: RESERVA, LLC, CALIFORNIA Effective Date: Dec 09, 2014
Jan 15, 2013	I	Issuance
Dec 22, 2012	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Nov 01, 2012	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARBOR DIVERSIFIED, INC.;REEL/FRAME:046629/0331 Owner name: HARBOR THERAPEUTICS, INC., CALIFORNIA Effective Date: Nov 01, 2012
Feb 01, 2012	AS	ASSIGNMENT	free format text: CHANGE OF NAME;ASSIGNOR:HARBOR BIOSCIENCES, INC.;REEL/FRAME:029227/0929 Owner name: HARBOR DIVERSIFIED, INC., CALIFORNIA Effective Date: Feb 01, 2012
Feb 09, 2010	AS	ASSIGNMENT	free format text: CHANGE OF NAME;ASSIGNOR:HOLLIS-EDEN PHARMACEUTICALS, INC.;REEL/FRAME:024066/0325 Owner name: HARBOR BIOSCIENCES, INC.,CALIFORNIA Effective Date: Feb 09, 2010 free format text: CHANGE OF NAME;ASSIGNOR:HOLLIS-EDEN PHARMACEUTICALS, INC.;REEL/FRAME:024066/0325 Owner name: HARBOR BIOSCIENCES, INC., CALIFORNIA Effective Date: Feb 09, 2010
Jun 26, 2008	P	Published
Mar 05, 2008	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FRINCKE, JAMES M.;READING, CHRISTOPHER;AUCI, DOMINICK;AND OTHERS;REEL/FRAME:020602/0745;SIGNING DATES FROM 20080226 TO 20080229 Owner name: HOLLIS-EDEN PHARMACEUTICALS, INC., CALIFORNIA free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FRINCKE, JAMES M.;READING, CHRISTOPHER;AUCI, DOMINICK;AND OTHERS;SIGNING DATES FROM 20080226 TO 20080229;REEL/FRAME:020602/0745 Owner name: HOLLIS-EDEN PHARMACEUTICALS, INC., CALIFORNIA
Nov 17, 2007	F	Filing
Nov 17, 2006	PD	Priority Date